Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: caplacizumab ×

caplacizumab

This drug is selected. Its supporting articles are shown below.

Caplacizumab2

Articles mentioning caplacizumab

2 articles · page 1 of 1

4CPS-117 Rituximab and caplacizumab in thrombotic thrombocytopenic purpura: 11 years of real-world evidence

ejhpharm · abstract · 2026-03-18 · 5 matching annotations

99.0%

Rituximab Caplacizumab Thrombotic thrombocytopenic purpura corticosteroids plasma exchange TTP

…nd corticosteroids, with relapses occurring in 20–50% of cases. Rituximab and caplacizumab (available since 2018) are currently used in c…

PO:04:115 Successful combination rescue therapy in SLE complicated by TTP, lupus nephritis, sepsis, HLH with severe hyperinflammatory cardiomyopathy, and hyperhaemolysis

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

91.2%

eculizumab rituximab anakinra caplicazumab caplacizumab methylprednisolone eculizumumab IV cyclophosphamide systemic lupus erythematosus SLE+1 more

… immunomodulation with combination targeted biologics—including eculizumab—may achieve full end-organ recovery despite life-threatening im…